ALX Oncology Holdings (ALXO) Competitor Comparison
We are evaluating the key criteria listed to compare ALX Oncology Holdings (ALXO) against its competitors in the Biotechnology industry.
Market Capitalization
138 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
251 / 337Free Cashflow
243 / 352Quick Ratio
176 / 357Earnings per Share
274 / 359Dividend yield
0 / 6Total Cash
163 / 358Performance 3 years
354 / 368Performance 5 years
332 / 368Performance 10 years
300 / 368Linearity 3 years
286 / 368Linearity 5 years
153 / 368Linearity 10 years
128 / 368Total Rank
286 / 368Dividend Rank
346 / 368Valuation Rank
347 / 368Piotroski Rank
116 / 368Muliplier Rank
264 / 368Quick Ratio - ALXO ranking 176 / 357
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.